Association of Postoperative Anaemia With Patient-centred Outcomes
1 other identifier
observational
3,000
1 country
1
Brief Summary
Primary aim - To investigate the relationship between postoperative anaemia and patient-centred outcomes after major abdominal surgery. Secondary aim - To determine whether a more liberal perioperative IV fluid strategy increases the risk of postoperative anaemia (haemodilution). Hypothesis: Adults with anaemia in the immediate postoperative period following major abdominal surgery have a poorer quality of recovery and higher risk of complications, leading to poor disability-free survival when compared with patients without postoperative anaemia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 16, 2021
CompletedStudy Start
First participant enrolled
July 16, 2021
CompletedFirst Posted
Study publicly available on registry
July 27, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2021
CompletedJuly 13, 2022
July 1, 2021
4 months
July 16, 2021
July 11, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Persistent disability or death by 90 days
Defined as a World Health Organization Disability Assessment Schedule 2.0 (WHODAS) score of at least 24 points (on the 48-point scale) at both 30 and 90 days postoperatively, reflecting a disability level of at least 25% and being the threshold point between "disabled" and "not disabled" as per WHO guidelines. Disability was assessed by the participant, but if unable then we used the proxy's report.
90 days after surgery
Secondary Outcomes (12)
Death: all-cause mortality at 90 days, then up to 12 months after surgery
1 year
A composite (pooled) and individual septic complications: sepsis, surgical site infection, anastomotic leak, and pneumonia
30 days
Sepsis: using Centers for Disease Control and Prevention (CDC) with National Healthcare Safety Network (NHSN) criteria
30 days
Surgical site infection
30 days
Pneumonia
30 days
- +7 more secondary outcomes
Study Arms (2)
Postoperative anemia
All patients enrolled in the RELIEF trial in which a postoperative Day 1-3 hemoglobin concentration was measured. Anaemia will be defined according to the World Health Organisation definition (males Hb \<130 g/L, and female Hb \<120 g/L).
No postoperative anemia
All patients enrolled in the RELIEF trial in which a postoperative Day 1-3 hemoglobin concentration was measured. No anaemia will be defined according to the World Health Organisation definition (males Hb ≥130 g/L, and females Hb ≥120 g/L).
Interventions
Depends on Day 3 Hb result
Eligibility Criteria
Adult, elective major abdominal surgery
You may qualify if:
- Adults (≥18 years) undergoing elective major surgery and providing informed consent
- All types of open or lap-assisted abdominal or pelvic surgery with an expected duration of at least 2 hours, and an expected hospital stay of at least 3 days
- At increased risk of postoperative complications, as defined by any of the following criteria:
- age ≥70 years
- known or documented history of coronary artery disease
- known or documented history of heart failure
- diabetes currently treated with an oral hypoglycemic agent and/or insulin
- preoperative serum creatinine \>200 micromol/L (\>2.8 mg/dl)
- morbid obesity (BMI ≥35 kg/m2)
- preoperative serum albumin \<30 g/L
- anaerobic threshold (if done) \<12 mL/kg/min
- or two or more of the following risk factors:
- ASA 3 or 4
- chronic respiratory disease
- obesity (BMI 30-35 kg/m2)
- +4 more criteria
You may not qualify if:
- Urgent or time-critical surgery
- ASA physical status 5 - such patients are not expected to survive with or without surgery, and their underlying illness is expected to have an overwhelming effect on outcome (irrespective of fluid therapy)
- Chronic renal failure requiring dialysis
- Pulmonary or cardiac surgery - different pathophysiology, and thoracic surgery typically have strict fluid restrictions
- Liver resection - most units have strict fluid/CVP limits in place and won't allow randomisation
- Minor or intermediate surgery, such as laparoscopic cholecystectomy, transurethral resection of the prostate, inguinal hernia repair, splenectomy, closure of colostomy - each of these are typically "minor" surgery with minimal IV fluid requirements, generally low rates of complications and mostly very good survival.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bayside Healthlead
- Monash Universitycollaborator
Study Sites (1)
Alfred Hospital
Melbourne, Victoria, 3004, Australia
Related Publications (2)
Myles PS, Bellomo R, Corcoran T, Forbes A, Peyton P, Story D, Christophi C, Leslie K, McGuinness S, Parke R, Serpell J, Chan MTV, Painter T, McCluskey S, Minto G, Wallace S; Australian and New Zealand College of Anaesthetists Clinical Trials Network and the Australian and New Zealand Intensive Care Society Clinical Trials Group. Restrictive versus Liberal Fluid Therapy for Major Abdominal Surgery. N Engl J Med. 2018 Jun 14;378(24):2263-2274. doi: 10.1056/NEJMoa1801601. Epub 2018 May 9.
PMID: 29742967BACKGROUNDMyles PS, Richards T, Klein A, Wood EM, Wallace S, Shulman MA, Martin C, Bellomo R, Corcoran TB, Peyton PJ, Story DA, Leslie K, Forbes A; RELIEF Trial Investigators. Postoperative anaemia and patient-centred outcomes after major abdominal surgery: a retrospective cohort study. Br J Anaesth. 2022 Sep;129(3):346-354. doi: 10.1016/j.bja.2022.06.014. Epub 2022 Jul 15.
PMID: 35843746DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 16, 2021
First Posted
July 27, 2021
Study Start
July 16, 2021
Primary Completion
October 31, 2021
Study Completion
November 30, 2021
Last Updated
July 13, 2022
Record last verified: 2021-07